Inventor
MACLACHLAN IAN
CA51 patents
⚠️ This page may combine multiple inventors who share the name “MACLACHLAN IAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROTIVA BIOTHERAPEUTICS INC
21 patentsUS9074208B2Jul 7, 2015
Modified siRNA molecules and uses thereof
PROTIVA BIOTHERAPEUTICS INC94 citations99
US7799565B2Sep 21, 2010
Lipid encapsulated interfering RNA
PROTIVA BIOTHERAPEUTICS INC367 citations99
US7745651B2Jun 29, 2010
Cationic lipids and methods of use
PROTIVA BIOTHERAPEUTICS INC368 citations99
US9504651B2Nov 29, 2016
Lipid compositions for nucleic acid delivery
PROTIVA BIOTHERAPEUTICS INC144 citations98
US9364435B2Jun 14, 2016
Lipid formulations for nucleic acid delivery
PROTIVA BIOTHERAPEUTICS INC194 citations98
US8999950B2Apr 7, 2015
Compositions and methods for silencing aldehyde dehydrogenase
PROTIVA BIOTHERAPEUTICS INC102 citations98
US8822668B2Sep 2, 2014
Lipid formulations for nucleic acid delivery
PROTIVA BIOTHERAPEUTICS INC99 citations98
US7982027B2Jul 19, 2011
Lipid encapsulated interfering RNA
PROTIVA BIOTHERAPEUTICS INC228 citations98
US7915399B2Mar 29, 2011
Modified siRNA molecules and uses thereof
PROTIVA BIOTHERAPEUTICS INC148 citations98
US7807815B2Oct 5, 2010
Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
PROTIVA BIOTHERAPEUTICS INC68 citations98
US7803397B2Sep 28, 2010
Polyethyleneglycol-modified lipid compounds and uses thereof
PROTIVA BIOTHERAPEUTICS INC313 citations98
US9492386B2Nov 15, 2016
Liposomal apparatus and manufacturing methods
PROTIVA BIOTHERAPEUTICS INC72 citations97
US9187748B2Nov 17, 2015
Compositions and methods for silencing ebola virus gene expression
PROTIVA BIOTHERAPEUTICS INC93 citations96
US9018187B2Apr 28, 2015
Cationic lipids and methods for the delivery of therapeutic agents
PROTIVA BIOTHERAPEUTICS INC116 citations96
US7901708B2Mar 8, 2011
Liposomal apparatus and manufacturing methods
PROTIVA BIOTHERAPEUTICS INC344 citations96
US9428751B2Aug 30, 2016
Compositions and methods for silencing apolipoprotein C-III expression
PROTIVA BIOTHERAPEUTICS INC80 citations95
US9878042B2Jan 30, 2018
Lipid formulations for delivery of therapeutic agents to solid tumors
PROTIVA BIOTHERAPEUTICS INC23 citations94
US6410328B1Jun 25, 2002
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
PROTIVA BIOTHERAPEUTICS INC55 citations92
US9926560B2Mar 27, 2018
Lipid encapsulating interfering RNA
PROTIVA BIOTHERAPEUTICS INC6 citations84
US9035039B2May 19, 2015
Compositions and methods for silencing SMAD4
PROTIVA BIOTHERAPEUTICS INC12 citations81
US6841537B1Jan 11, 2005
Combination therapy using nucleic acids and conventional drugs
PROTIVA BIOTHERAPEUTICS INC14 citations76
MACLACHLAN IAN
10 patentsUS8513403B2Aug 20, 2013
Modified siRNA molecules and uses thereof
MACLACHLAN IAN114 citations99
US8101741B2Jan 24, 2012
Modified siRNA molecules and uses thereof
MACLACHLAN IAN252 citations99
US8188263B2May 29, 2012
Modified siRNA molecules and uses thereof
MACLACHLAN IAN241 citations98
US8329070B2Dec 11, 2012
Liposomal apparatus and manufacturing method
MACLACHLAN IAN158 citations96
US7838658B2Nov 23, 2010
siRNA silencing of filovirus gene expression
MACLACHLAN IAN181 citations96
US9005654B2Apr 14, 2015
Systems and methods for manufacturing liposomes
MACLACHLAN IAN29 citations93
US9006191B2Apr 14, 2015
Silencing of polo-like kinase expression using interfering RNA
MACLACHLAN IAN19 citations92
US8598333B2Dec 3, 2013
SiRNA silencing of genes expressed in cancer
MACLACHLAN IAN27 citations92
US8227443B2Jul 24, 2012
Silencing of CSN5 gene expression using interfering RNA
MACLACHLAN IAN31 citations92
US9181545B2Nov 10, 2015
Lipid encapsulating interfering RNA
MACLACHLAN IAN1 citations63
ARBUTUS BIOPHARMA CORP
7 patentsUS11141378B2Oct 12, 2021
Lipid formulations for nucleic acid delivery
ARBUTUS BIOPHARMA CORP42 citations97
US12016929B2Jun 25, 2024
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP5 citations86
US11786598B2Oct 17, 2023
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP7 citations86
US11446383B2Sep 20, 2022
Lipid formulations for delivery of therapeutic agents
ARBUTUS BIOPHARMA CORP6 citations86
US11318098B2May 3, 2022
Liposomal apparatus and manufacturing methods
ARBUTUS BIOPHARMA CORP3 citations83
US11298320B2Apr 12, 2022
Liposomal apparatus and manufacturing methods
ARBUTUS BIOPHARMA CORP3 citations83
US10415037B2Sep 17, 2019
Compositions and methods for silencing hepatitis B virus gene expression
ARBUTUS BIOPHARMA CORP7 citations76
HEYES JAMES
3 patentsUS8569256B2Oct 29, 2013
Cationic lipids and methods for the delivery of therapeutic agents
HEYES JAMES485 citations97
US8936942B2Jan 20, 2015
Polyethyleneglycol-modified lipid compounds and uses thereof
HEYES JAMES111 citations96
US8865675B2Oct 21, 2014
Compositions and methods for silencing apolipoprotein B
HEYES JAMES12 citations83
YAWORSKI EDWARD
2 patentsYAWORSKI ED
1 patentLEE AMY C H
1 patentROBBINS MARJORIE
1 patentGEISBERT THOMAS W
1 patentMACDONALD MARCIA
1 patentUNIV BRITISH COLUMBIA
1 patentJUDGE ADAM
1 patentShowing the top 50 of 51 patents by PatentIndex Score.